The first Cidara Therapeutics trade was made in Q2 2015.
Since then Ken Griffin bought shares nineteen more times and sold shares on nineteen occasions. The investor completely sold their stake between Q2 2024 and Q2 2024.
Avg closing price
Price range
Sold -4.23 Thousand shares
Q2 2024
Avg closing price
$13.68
Price range
$10.25
-
$23.20
New holding (+4.23 Thousand shares)
Q1 2024
Avg closing price
$14.36
Price range
$12.82
-
$18.40
Sold -15.1 Thousand shares
Q1 2023
Avg closing price
$28.37
Price range
$15.00
-
$39.60
New holding (+15.1 Thousand shares)
Q4 2022
Avg closing price
$11.93
Price range
$9.52
-
$15.13
Sold -2.87 Thousand shares
Q3 2022
Avg closing price
$13.80
Price range
$8.98
-
$16.12
New holding (+2.87 Thousand shares)
Q2 2022
Avg closing price
$12.35
Price range
$8.56
-
$18.20
Sold -6.31 Thousand shares
Q1 2022
Avg closing price
$16.96
Price range
$13.35
-
$27.80
Increased shares by 392.1% (+5.03 Thousand shares)
Q4 2021